Storia in 10 fonti

Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics

The latest in a prolific streak of buyouts by Lilly is the strongest sign yet that large pharmaceutical companies may finally be embracing a long-dismissed field of research.

Raccontata da

biopharmadive.com

benzinga.com

economictimes.indiatimes.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

biopharmadive.comStai leggendo1 g fa

Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics

The latest in a prolific streak of buyouts by Lilly is the strongest sign yet that large pharmaceutical companies may finally be embracing a long-dismissed field of research.

originale

Timeline cronologica

giovedì 16 luglio 2026·biopharmadive.com
Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics
The latest in a prolific streak of buyouts by Lilly is the strongest sign yet that large pharmaceutical companies may finally be embracing a long-dismissed field of research.
giovedì 16 luglio 2026·benzinga.com
AtaiBeckley (ATAI) Stock Skyrockets 65% After-Hours on Eli Lilly Acquisition Talks - Eli Lilly (NYSE:LLY)
AtaiBeckley shares jumped 64.70% after hours following reports that Eli Lilly is in talks to acquire the psychedelic drugmaker at a premium.

Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics

Confronto fonti

Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics

Timeline cronologica

Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics

AtaiBeckley (ATAI) Stock Skyrockets 65% After-Hours on Eli Lilly Acquisition Talks - Eli Lilly (NYSE:LLY)

Lilly bets $2.8B upfront on psychedelics in deal to buy AtaiBeckley

Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley

Eli Lilly agrees to $3.8B psychedelic buy

Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction

Weight-loss drugmaker Lilly nears $1.97 bn AtaiBeckley's acquisition: Report

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction

Lilly bets $2.8B upfront on psychedelics in deal to buy AtaiBeckley

Eli Lilly punta sugli psichedelici: acquisirà AtaiBeckley per 2,8 miliardi di dollari | MilanoFinanza News

Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley

Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal

Eli Lilly comprará biofarmacêutica voltada a transtornos mentais por US$ 2,8 bilhões

Eli Lilly scommette sulla salute mentale: acquisita AtaiBeckley per 2,8 miliardi di dollari

Eli Lilly agrees to $3.8B psychedelic buy

AtaiBeckley Shares Surge as Eli Lilly Seals $3.8B Acquisition Deal - Eli Lilly (NYSE:LLY), AtaiBeckley (N